Global

Why You Should Still Hold Argos Therapeutics, Inc. (NASDAQ:ARGS) Stock Today

Argos Therapeutics, Inc. (NASDAQ:ARGS) fell by -2.80% in the last day from $0.30 to $0.29 and has now fallen 9 consecutive sessions. The price has fallen in 8 of the last 10 days and is down by -17.88% over the same course of time. There was a decrease in both volume and price. This is usually interpreted as a good sign as traders widely believe falling stock should see declining volume. Traded activity experienced a fall of -0.07 million shares and in total 1.11 M shares exchanged hands for about $322 678.

Inside ARGS’s Recent Trend

Argos Therapeutics, Inc. (ARGS) lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down through the resistance trend line at $0.28 will initially point to a quick declining speed. Short-term traders are anticipated to see a retreat of -26.98% over the course of a quarter and, with 90% chance the price will be floating in the range of $0.20 and $0.30 in this timeframe.

Argos Therapeutics, Inc. Technical Signals



ARGS has witnessed its long term and short term MA triggering a sell signal. Many traders watch for long-term averages to cross above short-term averages to signal the beginning of a downtrend. Upon corrections, the price will meet resistance from the averages between $0.32 and $0.38. A buy signal will be generated if it crosses above any of these levels. Its pivot point high generated sell signal on Wednesday June 21, 2017, which calls for additional declines until the stock forms a new pivot point low, as this could be a buying opportunity. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Argos Therapeutics, Inc. (NASDAQ:ARGS) Support And Resistance Levels

There is no support from accumulated volume below today’s level and given the right condition the stock may perform very badly in the next couple of days. In case of gains, the next resistance from accumulated volume will be at $0.36, $0.36 and $0.34.




Argos Therapeutics, Inc. (ARGS) Risk Assessment

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be high risk. In the most recent session, the stock price hovered around $0.02 between high and low, or 8.39%. For the last week the stock has had a daily average volatility of 9.34%.

Argos Therapeutics is in oversold territory based on Relative Strength Index reading (16). In some cases it takes more time for the trend to shift while the stock is being oversold and the Relative Strength Index keeps moving.

 

Previous ArticleNext Article

Related Post

Checking Out the Fundamental Data for Under Armour... Under Armour, Inc. (NYSE:UAA)'s interesting series of developments are underway around the US stock market these days. Now trading with a market value...
Is Anadarko Petroleum Corporation (APC) Investing ... Anadarko Petroleum Corporation (NYSE:APC) fell by -1.64% in Wednesday’s trading from $43.24 to $42.53. The price has fallen in 8 of the last 10 days a...
Envision Healthcare Corporation (EVHC): Checking t... Envision Healthcare Corporation (NYSE:EVHC) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade de...
Vodafone Group Plc (NASDAQ:VOD) Daily Technical Re... Vodafone Group Plc (NASDAQ:VOD) fell by -0.11% in Thursday’s trading session from $28.18 to $28.15 and has now fallen 3 consecutive sessions. The pric...
Why You Should Still Buy Flexion Therapeutics, Inc... Flexion Therapeutics, Inc. (NASDAQ:FLXN) gained 4.89% in yesterday’s session, going up from its prior closing price of $24.12 to $25.30, and has now r...

Leave a Reply

Your email address will not be published. Required fields are marked *